The Current Ratio as of December 2025 (TTM) for NuGenerex Immuno-Oncology, Inc. (NUGX) is 0.03

According to NuGenerex Immuno-Oncology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.03. This represents a change of -11.77% compared to the average of 0.03 of the last 4 quarters.

NuGenerex Immuno-Oncology, Inc. (NUGX) Historical Current Ratio (quarterly & annually)

How has NUGX Current Ratio performed in the past?

The mean historical Current Ratio of NuGenerex Immuno-Oncology, Inc. over the last ten years is 0.14. The current 0.03 Current Ratio has changed 2.03% with respect to the historical average. Over the past ten years (40 quarters), NUGX's Current Ratio was at its highest in in the April 2014 quarter at 0.51. The Current Ratio was at its lowest in in the October 2016 quarter at 0.00.

NuGenerex Immuno-Oncology, Inc. (NUGX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NuGenerex Immuno-Oncology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NuGenerex Immuno-Oncology, Inc. (NUGX) Average Current Ratio

How has NUGX Current Ratio performed in the past?

The current Current Ratio of NuGenerex Immuno-Oncology, Inc. (NUGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NuGenerex Immuno-Oncology, Inc. (NUGX) Current Ratio vs. Peers

How is NUGX’s Current Ratio compared to its peers?

NuGenerex Immuno-Oncology, Inc.’s Current Ratio is less than Navidea Biopharmaceuticals, Inc. (0.32), less than WPD Pharmaceuticals Inc. (0.10), greater than Nanomix Corporation (0.02), less than NeonMind Biosciences Inc. (0.19), less than Gelesis Holdings, Inc. (0.46), less than Goodbody Health Limited (2.03), less than Advanzeon Solutions, Inc. (0), less than Gene Biotherapeutics, Inc. (0.08), less than MobileSmith, Inc. (0.12), less than MagForce AG (0.19),

Build a custom stock screener for NuGenerex Immuno-Oncology, Inc. (NUGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NuGenerex Immuno-Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NuGenerex Immuno-Oncology, Inc. (NUGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NuGenerex Immuno-Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.